Dysregulation of the E-Cadherin/Catenin Complex by Irreversible Mutations in Human Carcinomas

References

• Aberle H., Butz S., Stappert J., Weissig H., Kemler R., Hoschuetzky H. Assembly of the cadherin catenin complex in vitro with recombinant proteins. J. Cell Sci. 1994; 107: 3655–3663
   PubMed Web of Science ®Google Scholar
• Aberle H., Bierkamp C., Torchard D., Serova O., Wagner T., Natt E., Wirsching J., Heidkamper C., Montagna M., Lynch H. T., Lenoir G. M., Scherer G., Feunteun J., Kemler R. The human plakoglobin gene localizes on chromosome 17g21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc. Natl. Acad. Sci. USA 1995; 92: 6384–6388
   PubMed Web of Science ®Google Scholar
• Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin–proteasome pathway. EMBO J. 1997; 16: 3797–3804
   PubMed Web of Science ®Google Scholar
• Beaudet A. L., Tsui L.-C. A suggested nomenclature for designating mutations. Hum. Mutat. 1993; 2: 245–248
   PubMed Web of Science ®Google Scholar
• Becker K.-F., Atkinson M. J., Reich U., Huang H.-H., Nekarda H., Siewert J. R., Höfler H. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum. Moles. Genet. 1993; 2: 803–804
   PubMed Web of Science ®Google Scholar
• Becker K.-F., Atkinson M. J., Reich U., Becker I., Nekarda H., Siewert J. R., Höfler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994; 54: 3845–3852
   PubMed Web of Science ®Google Scholar
• Behrens J., von Kries J. P., Kühl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional inter-action of beta-catenin with the transcription factor LEF-l. Nature 1996; 382: 638–642
   PubMed Web of Science ®Google Scholar
• Berx G., Staes K., van Hengel J., Molemans F., Bussemakers M. J.G., van Bokhoven A., van Roy F. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDHI). Genomics 1995; 26: 281–289
   PubMed Web of Science ®Google Scholar
• Berx G., Cleton-Jansen A.-M., Nollet F., de Leeuw W. J.F., van de Vijver M. J., Cornelisse C., van Roy F. E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995; 14: 6107–6115
   PubMed Web of Science ®Google Scholar
• Berx G., Cleton-Jansen A.-M., Strumane K., de Leeuw W. J.F., Nollet F., van Roy F. M., Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996; 13: 1919–1925
   PubMed Web of Science ®Google Scholar
• Birchmeier W., Behrens J. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys., Acta – Rev. Cancer 1994; 1198: 11–26
   PubMed Web of Science ®Google Scholar
• Brabant G., Hoangvu C., Cetin Y., Dralle H., Scheumann G., Molne J., Hansson G., Jansson S., Ericson L. E., Nilsson M. E-cadherin – a differentiation marker in thyroid malignancies. Cancer Res. 1993; 53: 4987–4993
   PubMed Web of Science ®Google Scholar
• Bracke M. E., van Roy F. M., Mareel M. M. The E-cadherin/catenin complex in invasion and metastasis. Current Topics Microbiology and Immunology: Attempts to Understand Metastasis Formation I, U. Günthert, W. Birchmeier. Springer Verlag, Berlin 1996; Vol. 213/I: 123–161
   Google Scholar
• Bussemakers M. J., van-Bokhoven A., Mees S. G., Kemler R., Schalken J. A. Molecular cloning and characterization of the human E-cadherin cDNA. Mol. Biol. Rep. 1993; 17: 123–128
   PubMed Web of Science ®Google Scholar
• Candidus S., Bischoff P., Becker K. F., Hofler H. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res. 1996; 56: 49–52
   PubMed Web of Science ®Google Scholar
• Carter B. S., Ewing C. M., Ward W. S., Treiger B. F., Aalders T. W., Schalken J. A., Epstein J. I., Isaacs W. B. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA 1990; 87: 8751–8755
   PubMed Web of Science ®Google Scholar
• Cleton-Jansen A.-M., Moerland E. W., Kuipers-Dijkshoorn N. J., Callen D. F., Sutherland G. R., Hansen B., Devilee P., Cornelisse C. J. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Gene Chromos. Cancer 1994; 9: 101–107
   PubMed Web of Science ®Google Scholar
• Cowin P. Unraveling the cytoplasmic interactions of the cadherin superfamily. Proc. Natl. Acad. Sci. USA 1994; 91: 10759–10761
   PubMed Web of Science ®Google Scholar
• Daar I. O., Maquat L. E. Premature translation termination mediates triosphosphate isomerase mRNA degradation. Mol. Cell. Biol. 1988; 8: 802–813
   PubMed Web of Science ®Google Scholar
• de Leeuw W. J.F., Berx G., Vos C. B.J., Peterse J. L., van de Vijver M. J., Litvinov S., van Roy F. M., Cornelisse C. J., Cleton-Jansen A.-M. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J. Pathol. 1997; 183: 404–411
   PubMed Web of Science ®Google Scholar
• Ewing C. M., Ru N., Morton R. A., Robinson J. C., Wheelock M. J., Johnson K. R., Barrett J. C., Isaacs W. B. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alphacatenin and restoration of E-cadherin function. Cancer Res. 1995; 55: 4813–4817
   PubMed Web of Science ®Google Scholar
• Frixen U. H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Lochner D., Birchmeier W. E-cadherin-mediated cell–cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 1991; 113: 173–185
   PubMed Web of Science ®Google Scholar
• Furukawa Y., Nakatsuru S., Nagafuchi A., Tsukita S., Muto T., Nakamura Y., Horii A. Structure, expression and chromosome assignment of the human catenin (cadherinassociated protein) alpha-1 gene (CTNNA 1). Cytogenet. Cell Genet. 1994; 65: 74–78
   PubMedGoogle Scholar
• Gamallo C., Palacios J., Suarez A., Pizarro A., Navarro P., Quintanilla M., Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol. 1993; 142: 987–993
   PubMed Web of Science ®Google Scholar
• Graff J. R., Herman J. G., Lapidus R. G., Chopra H., Xu R., Jarrard D. F., Isaacs W. B., Pitha P. M., Davidson N. E., Baylin S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995; 55: 5195–5199
   PubMed Web of Science ®Google Scholar
• Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A. E. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402–405
   PubMed Web of Science ®Google Scholar
• Hennig G., Behrens J., Truss M., Frisch S., Reichmann E., Birchmeier W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 1995; 11: 475–484
   PubMed Web of Science ®Google Scholar
• Herman J. G., Graff J. R., Myohanen S., Nelkin B. D., Baylin S. B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996; 93: 9821–9826
   PubMed Web of Science ®Google Scholar
• Herrenknecht K., Ozawa M., Eckerskorn C., Lottspeich F., Lenter M., Kemler R. The uvomorulin-anchorage protein alpha-catenin is a vinculin homologue. Proc. Natl. Acad. Sci. USA 1991; 88: 9156–9160
   PubMed Web of Science ®Google Scholar
• Hirano S., Kimoto N., Shimoyama Y., Hirohashi S., Takeichi M. Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization. Cell 1992; 70: 293–301
   PubMed Web of Science ®Google Scholar
• Hülsken J., Birchmeier W., Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J. Cell Biol. 1994; 127: 2061–2069
   PubMed Web of Science ®Google Scholar
• Ilyas M., Tomlinson I. P.M., Rowan A., Pignatelli M., Bodmer W. F. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. USA 1997; 94: 10330–10334
   PubMed Web of Science ®Google Scholar
• Ji X. D., Woodard A. S., Rimm D. L., Fearon E. R. Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ. 1997; 8: 773–778
   PubMedGoogle Scholar
• Jou T. S., Stewart D. B., Stappert J., Nelson W. J., Marrs J. A. Genetic and biochemical dissection of protein linkages in the cadherin–catenin complex. Proc. Natl. Acad. Sci. USA 1995; 92: 5067–5071
   PubMed Web of Science ®Google Scholar
• Kadowaki T., Shiozaki H., Inoue M., Tamura S., Oka H., Doki Y., Iihara K., Matsui S., Iwazawa T., Nagafuchi A., Tsukita S., Mori T. E-cadherin and alphacatenin expression in human esophageal cancer. Cancer Res. 1994; 54: 291–296
   PubMed Web of Science ®Google Scholar
• Kanai Y., Ushijima S., Hui A. M., Ochiai A., Tsuda H., Sakamoto M., Hirohashi S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer 1997; 71: 355–359
   PubMed Web of Science ®Google Scholar
• Kas K., Voz M. L., Roijer E., Astrom A. K., Meyen E., Stenman G., Vande Ven W. J.M. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat. Genet. 1997; 15: 170–174
   PubMed Web of Science ®Google Scholar
• Kawanishi J., Kato J., Sasaki K., Fujii S., Watanabe N., Niitsu Y. Loss of E-cadherin-dependent cell–cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol. Cell. Biol. 1995; 15: 1175–1181
   PubMed Web of Science ®Google Scholar
• Knudsen K. A., Soler A. P., Johnson K. R., Wheelock M. J. Interaction of alpha-actinin with the cadherin/catenin cell–cell adhesion complex via alpha-catenin. J. Cell Biol. 1995; 130: 67–77
   PubMed Web of Science ®Google Scholar
• Kok K., van den Berg A., Veldhuis P. M.J.F., van der Veen A. Y., Franke M., Schoenmakers E. F.P.M., Hulsbeek M. M.F., van der Hout A. H., de Leij L., van de Ven W., Buys C. H.C.M. A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artifical chromosomes. Cancer Res. 1994; 54: 4183–4187
   PubMed Web of Science ®Google Scholar
• Korinek V., Barker N., Morin P. J., van Wichen D., de Weger R., Kinzler K. W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784–1786
   PubMed Web of Science ®Google Scholar
• Kraus C., Liehr T., Hulsken J., Behrens J., Birchmeier W., Grzeschik K. H., Ballhausen W. G. Localization of the human beta-catenin gene (CTNNBI) to 3p21: a region implicated in tumor development. Genomics 1994; 23: 272–274
   PubMed Web of Science ®Google Scholar
• Li C., Berx G., Larsson C., Auer G., Aspenblad U., Pan Y., Sundelin B., Ekman M., van Roy F., Bergerheim U. S.R. Lack of somatic E-cadherin mutations in prostate cancer and localization of distinct deleted regions on chromosome 16q associated with metastases, Submitted for publication
   Google Scholar
• Mansouri A., Spurr N., Goodfellow P. N., Kemler R. Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 1988; 38: 67–71
   PubMed Web of Science ®Google Scholar
• Mareel M., Berx G., Van Roy F., Bracke M. The cadherin/catenin complex: a target for antiinvasive therapy?. J. Cell. Biochem. 1996; 61: 524–530
   PubMed Web of Science ®Google Scholar
• Merlo A., Herman J. G., Mao L., Lee D. J., Gabrielson E., Burger P. C., Baylin S. B., Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1995; 1: 686–692
   PubMed Web of Science ®Google Scholar
• Miller J. R., Moon R. T. Signal transduction through beta-catenin and specification of cell fate during embryo-genesis. Gene Develop. 1996; 10: 2527–2539
   PubMed Web of Science ®Google Scholar
• Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destree O., Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86: 391–399
   PubMed Web of Science ®Google Scholar
• Moll R., Mitze M., Frixen U. H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 1993; 143: 1731–1742
   PubMed Web of Science ®Google Scholar
• Morin P. J., Sparks A. B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K. W. Activation of betacatenin-Tcf signalling in colon cancer by mutations in betacatenin or APC. Science 1997; 275: 1787–1789
   PubMed Web of Science ®Google Scholar
• Morton R. A., Ewing C. M., Nagafuchi A., Tsukita S., Isaacs W. B. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res. 1993; 53: 3585–3590
   PubMed Web of Science ®Google Scholar
• Muta H., Noguchi M., Kanai Y., Ochiai A., Nawata H., Hirohashi S. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn. J. Cancer Res. 1996; 87: 843–848
   PubMedGoogle Scholar
• Nagafuchi A., Takeichi M., Tsukita S. The 102kd cadherin-associated protein: Similarity to vinculin and post-transcriptional regulation of expression. Cell 1991; 65: 849–857
   PubMed Web of Science ®Google Scholar
• Natt E., Magenis R. E., Zimmer J., Mansouri A., Scherer G. Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet. Cell Genet. 1989; 50: 145–148
   PubMedGoogle Scholar
• Navarro P., Gomez M., Pizarro A., Gamallo C., Quintanilla M., Cano A. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J. Cell Biol. 1991; 115: 517–533
   PubMed Web of Science ®Google Scholar
• Nollet F., van Hengel J., Berx G., Molemans F., van Roy F. Isolation and characterization of a human pseudogene (CTNNAP1) for alpha-E-catenin (CTNNAI): Assignment of the pseudogene to 5q22 and the alpha-E-catenin gene to 5q31. Genomics 1995; 26: 410–413
   PubMed Web of Science ®Google Scholar
• Nollet F., Berx G., Molemans F., van Roy F. Genomic organization of the human beta-catenin gene (CTNNBI). Genomics 1996; 32: 413–424
   PubMed Web of Science ®Google Scholar
• Nollet F., van den Berg A., Kersemaekers A.-M., Cleton-Jansen A.-M., Berx G., van der Veen A. Y., Eichperger C., Wieland I., De Gréve J., Liefers G.-J., Xiao W.-H., Buys C. H.C.M., Cornelisse C., van Roy F. Allelic imbalance at the beta-catenin gene (CTNNB1 at 3p22–21.3) in various human tumor types. Int. J. Oncol. 1997; 11: 311–318
   PubMed Web of Science ®Google Scholar
• Oda T., Kanai Y., Shimoyama Y., Nagafuchi A., Tsukita S., Hirohashi S. Cloning of the human alphacatenin cDNA and its aberrant messenger RNA in a human cancer cell line. Biochem. Biophys. Res. Commun. 1993; 193: 897–904
   PubMed Web of Science ®Google Scholar
• Oda T., Kanai Y., Oyama T., Yoshiura K., Shimoyama Y., Birchmeier W., Sugimura T., Hirohashi S. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA 1994; 91: 1858–1862
   PubMed Web of Science ®Google Scholar
• Ohtani-Fujita N., Aoike A., Osifchin N. E., Robbins P. D., Sakai T. CpG methylation inactivates the promotor activity of the human retinoblastoma tumor suppressor gene. Oncogene 1993; 8: 1063–1067
   PubMed Web of Science ®Google Scholar
• Oyama T., Kanai Y., Ochiai A., Akimoto S., Oda T., Yanagihara K., Nagafuchi A., Tsukita S., Shibamoto S., Ito F., Takeichi M., Matsuda H., Hirohashi S. A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of inter-cellular adhesiveness in human cancer cell lines. Cancer Res. 1994; 54: 6282–6287
   PubMed Web of Science ®Google Scholar
• Ozawa M., Terada H., Pedraza C. The fourth armadillo repeat of plakoglobin (gamma-catenin) is required for its high affinity binding to the cytoplasmic domains of E-cadherin and desmosomal cadherin dsg2, and the tumor suppressor APC protein. Journal of Biochemistry 1995; 118: 1077–1082
   PubMed Web of Science ®Google Scholar
• Peifer M., Sweeton D., Casey M., Wieschaus E. Wingless signal and zeste-white 3 kinase trigger opposing changes in the intracellular distribution of armadillo. Development 1994; 120: 369–380
   PubMed Web of Science ®Google Scholar
• Rasbridge S. A., Gillett C. E., Sampson S. A., Walsh F. S., Millis R. R. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol. 1993; 169: 245–250
   PubMed Web of Science ®Google Scholar
• Reynolds A. B., Daniel J., McCrea P. D., Wheelock M. J., Wu J., Zhang Z. Identification of a new catenin: the tyrosine kinase substrate p 120(cas) associates with E-cadherin complexes. Mol. Cell. Biol. 1994; 14: 8333–8342
   PubMed Web of Science ®Google Scholar
• Rimm D. L., Sinard J. H., Morrow J. S. Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab. Invest. 1995; 72: 506–512
   PubMed Web of Science ®Google Scholar
• Risinger J. I., Berchuck A., Kohler M. F, Boyd J. Mutations of the E-cadherin gene in human gynecologic cancers. Nat. Genet. 1994; 7: 98–102
   PubMed Web of Science ®Google Scholar
• Robbins P. F., ElGamil M., Li Y. F., Kawakami Y., Loftus D., Appella E., Rosenberg S. A. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 1996; 183: 1185–1192
   PubMed Web of Science ®Google Scholar
• Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790–1792
   PubMed Web of Science ®Google Scholar
• Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 1990; 50: 7184–7189
   PubMed Web of Science ®Google Scholar
• Soares P., Berx G., van Roy F., Sobrinho-Simoes M. E-cadherin gene alterations are rare events in thyroid tumors. Int. J. Cancer 1997; 70: 32–38
   PubMed Web of Science ®Google Scholar
• Sommers C. L., Thompson E. W., Torri J. A., Kemler R., Gelmann E. P., Byers S. W. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Differ. 1991; 2: 365–372
   PubMedGoogle Scholar
• Takayama T., Shiozaki H., Inoue M., Tamura S., Oka H., Kadowaki T., Takatsuka Y., Nagafuchi A., Tsukita S., Mori T. Expression of E-cadherin and alphacatenin molecules in human breast cancer tissues and association with clinicopathological features. Int. J. Oncol. 1994; 5: 775–780
   PubMed Web of Science ®Google Scholar
• Takayama T., Shiozaki H., Shibamoto S., Oka H., Kimura Y., Tamura S., Inoue M., Monden T., Ito F., Monden M. Beta-catenin expression in human cancers. Am. J. Pathol. 1996; 148: 39–46
   PubMed Web of Science ®Google Scholar
• Takeichi M., Hirano S., Matsuyoshi N., Fujimori T. Cytoplasmic control of cadherin-mediated cell-cell adhesion. Cold Spring Harbor Symp. Quant. Biol. 1992; 57: 327–334
   PubMedGoogle Scholar
• Tamura G., Sakata K., Nishizuka S., Maesawa C., Suzuki Y., Iwaya T., Terashima M., Saito K., Satodate R. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn. J. Cancer Res. 1996; 87: 1153–1159
   PubMedGoogle Scholar
• Trent J. M., Wiltshire R., Su L. K., Nicolaides N. C., Vogelstein B., Kinzler K. W. The gene for the APC-binding protein beta-catenin (CTNNBI) maps to chromosome 3p22, a region frequently altered in human malignancies. Cytogenet. Cell Genet. 1995; 71: 343–344
   PubMedGoogle Scholar
• Uchida N., Shimamura K., Miyatani S., Copeland N. G., Gilbert D. J., Jenkins N. A., Takeichi M. Mouse alpha-N-catenin: Two isoforms, specific expression in the nervous system, and chromosomal localization of the gene. Dev. Biol. 1994; 163: 75–85
   PubMed Web of Science ®Google Scholar
• Umbas R., Schalken J. A., Aalders T. W., Carter B. S., Karthaus H. F.M., Schaafsma H. E., Debruyne F. M.J., Isaacs W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 1992; 52: 5104–5109
   PubMed Web of Science ®Google Scholar
• Van Hengel J., Nollet F., Berx G., van Roy N., Speleman F., van Roy F. Assignment of the human β-catenin gene (CTNNBI) to 3p22-p21.3 by fluorescence in situ hybridization. Cytogenet. Cell Genet. 1995; 70: 68–70
   PubMedGoogle Scholar
• Vermeulen S. J., Bruyneel E. A., Bracke M. E., De Bruyne G. K., Vennekens K. M., Vleminckx K. L., Berx G. J., van Roy F. M., Marcel M. M. Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells. Cancer Res. 1995; 55: 4722–4728
   PubMed Web of Science ®Google Scholar
• Vermeulen S., Nollet F., Teugels E., Malfait F., Vennekens K. M., Malfait F., Phillippé J., Speleman F., Bracke M. E., van Roy F. M., Marcel M. The alpha-E-catenin gene (CTNNA 1) acts as an invasion-suppressor gene in human colon cancer cells. 1998, Submitted for publication
   Google Scholar
• Vleminckx K., Vakaet L., Jr., Marcel M., Fiers W., van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107–119
   PubMed Web of Science ®Google Scholar
• Vos C. B.J., Cleton-Jansen A.-M., de Leeuw W. J.F., ter Haar N. T., Berx G., van Roy F., Cornelisse C. J., Peterse J. L., van de Vijver M. J. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumourigenesis. Br. J. Cancer 1997; 76: 1131–1133
   PubMed Web of Science ®Google Scholar
• Watabe M., Nagafuchi A., Tsukita S., Takeichi M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin catenin adhesion system in a dispersed carcinoma line. J. Cell Biol. 1994; 127: 247–256
   PubMed Web of Science ®Google Scholar
• Whitehead I., Kirk H., Kay R. Expression cloning of oncogenes by retroviral transfer of cDNA libraries. Mol. Cell. Biol. 1995; 15: 704–710
   PubMed Web of Science ®Google Scholar
• Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugimura T., Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 1995; 92: 7416–7419
   PubMed Web of Science ®Google Scholar